title: [Case of primary malignant lymphoma of the liver treated by R-CHOP therapy].
abstract: A 75-year-old man was admitted to our hospital because of right hypochondralgia. Computed tomography (CT) revealed a large tumor in the right lobe of the liver. Ultrasonography (US) showed vessels in the tumor. Needle biopsy specimens showed malignant lymphoma (Diffuse large B cell lymphoma). Ga scintigraphy and FDG-PET did not demonstrate other lesions and the definitive diagnosis was primary malignant lymphoma of the liver. CHOP with Rituximab therapy (R-CHOP therapy) was performed. After 8 courses of therapy the FDG-PET results were negative and we considered complete remission. We describe a case of primary malignant lymphoma of the liver treated successfully by R-CHOP therapy.
authors.affiliation: Department of Internal Medicine, Mitoyo General Hospital, Japan. aasagi@shikoku-cc.go.jp
authors.forename: Akinori
authors.initials: A
authors.lastname: Asagi
authors.forename: Yasuhiro
authors.initials: Y
authors.lastname: Miyake
authors.forename: Masaharu
authors.initials: M
authors.lastname: Ando
authors.forename: Hisae
authors.initials: H
authors.lastname: Yasuhara
authors.forename: Kazuyuki
authors.initials: K
authors.lastname: Matsumoto
authors.forename: Masahiro
authors.initials: M
authors.lastname: Takahara
authors.forename: Daisuke
authors.initials: D
authors.lastname: Kawai
authors.forename: Eisuke
authors.initials: E
authors.lastname: Kaji
authors.forename: Tatsuya
authors.initials: T
authors.lastname: Toyokawa
authors.forename: Toru
authors.initials: T
authors.lastname: Onishi
authors.forename: Katsuya
authors.initials: K
authors.lastname: Miyatani
authors.forename: Morihito
authors.initials: M
authors.lastname: Nakatsu
mesh_terms: D000369:Aged, 80 and over; D000911:Antibodies, Monoclonal / Q000008:administration & dosage; D058846:Antibodies, Monoclonal, Murine-Derived; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000008:administration & dosage; D003952:Diagnostic Imaging; D004317:Doxorubicin / Q000008:administration & dosage; D006801:Humans; D008113:Liver Neoplasms / Q000175:diagnosis / Q000188:drug therapy*; D016393:Lymphoma, B-Cell / Q000175:diagnosis / Q000188:drug therapy*; D016403:Lymphoma, Large B-Cell, Diffuse / Q000175:diagnosis / Q000188:drug therapy*; D008297:Male; D011239:Prednisolone / Q000008:administration & dosage; D012074:Remission Induction; D000069283:Rituximab; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011239:Prednisolone